Marks R, Whittle M W
Br Med J. 1969 Dec 27;4(5686):772-5. doi: 10.1136/bmj.4.5686.772.
Twenty-one patients with dermatitis herpetiformis initially controlled by dapsone or sulphonamides have been treated with a gluten-free diet and reassessed at intervals for up to 15 months (mean 11.9 months). According to routine histological and dissecting microscope criteria the small-bowel lesion improved in 10, but when mean epithelial cell height was used as a measure 15 patients improved. Five of the patients with diarrhoea improved after withdrawing gluten from the diet but none reverted to completely normal bowel habit. The tests for malabsorption showed little improvement in the treatment period. Twelve patients needed less dapsone to control their skin complaint, the mean dose falling from 144 mg. to a mean of 70 mg. per day; of these three stopped using this drug altogether.
21例最初用氨苯砜或磺胺类药物控制的疱疹样皮炎患者接受了无麸质饮食治疗,并每隔一段时间重新评估,最长达15个月(平均11.9个月)。根据常规组织学和解剖显微镜标准,10例患者的小肠病变有所改善,但以平均上皮细胞高度作为衡量标准时,15例患者有所改善。5例腹泻患者在饮食中去除麸质后病情有所改善,但无一例恢复到完全正常的肠道习惯。吸收不良测试在治疗期间几乎没有改善。12例患者控制皮肤症状所需的氨苯砜减少,平均剂量从每天144毫克降至平均70毫克;其中3例完全停用了这种药物。